Emily Blyth
Associate Professor
B.Med(Hons)/ FRACP/ FRCPA/ PhD
Emily.blyth@wimr.org.au
Blood Transplant & Cell Therapies Group
Currently open to PHD and Honours students in the topic areas of:
Transplant immune reconstitution & Cell therapy

Biography
A/Prof Blyth is a clinical and laboratory haematologist, blood transplant and cell therapies physician and the Clinical Lead for the Immune Effector Cell Service at Westmead Hospital. She is a Research Lead with the Westmead T cell Therapies Group with a focus on utilising cellular therapies to improve outcomes for patients with blood cancers. She has developed new therapeutic products that have been tested in successful human trials and explored their biologic activity in recipients with the goal to improve efficacy.
She is a leader in the field of cellular therapy, is the ANZ Regional Vice President for the International Society for Cell and Gene Therapy (2024-2026) and has received a number of awards including Cancer Institute of New South Wales Outstanding Cancer Research Fellow in 2021, and is current NSW Ministry of Health Cell and Gene Therapy Early/Mid Career Fellow.
Research interests
Cellular therapy, Blood transplant, Immune reconstitution, Clinical trials
Adjunct roles
Senior Staff Specialist Haematologist, Clinical Lead for Immune Effector Cells | Westmead Hospital |
Associate Professor | University of Sydney |
Additional information
ORCID: https://orcid.org/0000-0002-7849-7139
Google scholar: https://scholar.google.com/citations?user=7Ao7uyIAAAAJ&hl=en
Scopus ID: 23134646100
USYD link – https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/emily-blyth.html
Current grants
NSW Office of Health and Medical Research | 2021-2024 | Cell and Gene Therapy EMCR Fellowship Title: Safer and more effective transplants, cellular therapy interventions to improve outcomes in haematological malignancy |
MRFF | 2021-2024 | Rare Cancers, Rare Diseases and Unmet Needs |
NSW Office of Health and Medical Research | 2021-2022 | COVID Grants Round 2 Title: Manufacture of a cell bank of SARS-CoV2 T cells for clinical use |
NSW Cancer Institute | 2019-2021 | Early Career Fellowship Title: development and clinical implementation of cell therapies for haematological malignancies |
NHMRC | 2015-2019 | Translational Program Grant Title: Establishment of a comprehensive pipeline for T-cell immunotherapies - from bench to standard of care |
NSW Office of Health and Medical Research | 2019-2022 | Cell and Gene Therapy Project Grant Title: A randomised trial of partially HLA Matched pathogen specific T cells for the treatment of infection in patients undergoing blood stem cell transplant |
Affiliations
Westmead Hospital, University of Sydney
Professional Associations and Organisations
2024-2026 | International Society for Cell and Gene Therapy | Vice President for the ANZ Region |
2022-2024 | International Society for Cell and Gene Therapy | Vice President for the ANZ Region |
Haematology Society of Australia and New Zealand | Member | |
American Society of Hematology | Member | |
Australian Leukaemia and Lymphoma Group | Member | |
International Society of Cellular Therapy | Member |
Awards and recognition
2021 NSW Premier’s Outstanding Cancer Research Early Career Fellow of the Year |